Pre-Exposure Prophylaxis

0
Pipeline Programs
3
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GS
Gilead SciencesFOSTER CITY, CA
2 programs
Financial IncentiveN/A1 trial
Financial IncentiveN/A
Active Trials
NCT03078153Completed57Est. Dec 2020
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Financial IncentiveN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Gilead SciencesFinancial Incentive

Clinical Trials (1)

Total enrollment: 57 patients across 1 trials

NCT03078153Gilead SciencesFinancial Incentive

Effect of Social Media Support and Financial Incentives on PrEP Adherence

Start: Apr 2017Est. completion: Dec 202057 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space